DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name ▼ | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C1306459 | Primary malignant neoplasm | CLEC7A | 64581 | C-type lectin domain containing 7A | Q9BXN2 |
C1306459 | Primary malignant neoplasm | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C1306459 | Primary malignant neoplasm | SLC5A1 | 6523 | solute carrier family 5 member 1 | P13866 |
C1306459 | Primary malignant neoplasm | SFTPA1 | 653509 | surfactant protein A1 | Q8IWL2 |
C1306459 | Primary malignant neoplasm | SLC2A4 | 6517 | solute carrier family 2 member 4 | P14672 |
C1306459 | Primary malignant neoplasm | SIGLEC1 | 6614 | sialic acid binding Ig like lectin 1 | Q9BZZ2 |
C1306459 | Primary malignant neoplasm | TM7SF2 | 7108 | transmembrane 7 superfamily member 2 | O76062 |
C1306459 | Primary malignant neoplasm | ICAM5 | 7087 | intercellular adhesion molecule 5 | Q9UMF0 |
C1306459 | Primary malignant neoplasm | SFTPA2 | 729238 | surfactant protein A2 | Q8IWL1 |
C1306459 | Primary malignant neoplasm | SMPD2 | 6610 | sphingomyelin phosphodiesterase 2 | O60906 |
C1306459 | Primary malignant neoplasm | VCAM1 | 7412 | vascular cell adhesion molecule 1 | P19320 |
C1306459 | Primary malignant neoplasm | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
C1306459 | Primary malignant neoplasm | DHDDS | 79947 | dehydrodolichyl diphosphate synthase subunit | Q86SQ9 |
C1306459 | Primary malignant neoplasm | PIP4K2C | 79837 | phosphatidylinositol-5-phosphate 4-kinase type 2 gamma | Q8TBX8 |
C1306459 | Primary malignant neoplasm | SCD5 | 79966 | stearoyl-CoA desaturase 5 | Q86SK9 |
C1306459 | Primary malignant neoplasm | CERS4 | 79603 | ceramide synthase 4 | Q9HA82 |
C1306459 | Primary malignant neoplasm | LPCAT1 | 79888 | lysophosphatidylcholine acyltransferase 1 | Q8NF37 |
C1306459 | Primary malignant neoplasm | ACSS3 | 79611 | acyl-CoA synthetase short chain family member 3 | Q9H6R3 |
C1306459 | Primary malignant neoplasm | ULBP2 | 80328 | UL16 binding protein 2 | Q9BZM5 |
C1306459 | Primary malignant neoplasm | ULBP1 | 80329 | UL16 binding protein 1 | Q9BZM6 |
C1306459 | Primary malignant neoplasm | PNPLA3 | 80339 | patatin like phospholipase domain containing 3 | Q9NST1 |
C1306459 | Primary malignant neoplasm | PLA2G10 | 8399 | phospholipase A2 group X | O15496 |
C1306459 | Primary malignant neoplasm | PLA2G6 | 8398 | phospholipase A2 group VI | O60733 |
C1306459 | Primary malignant neoplasm | PDHX | 8050 | pyruvate dehydrogenase complex component X | O00330 |
C1306459 | Primary malignant neoplasm | PIP5K1B | 8395 | phosphatidylinositol-4-phosphate 5-kinase type 1 beta | O14986 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024